Medicinal Cannabis Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Medicinal Cannabis Market Analysis — Presence
Geographical Analysis
Click countries to exploreRegional and Country Analysis
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | xxxx | xxxx | xxxx | 24.5% |
| North America | xxxx | xxxx | xxxx | xxxx |
| United States | xxxx | xxxx | xxxx | xxxx |
| Canada | xxxx | xxxx | xxxx | xxxx |
| Mexico | xxxx | xxxx | xxxx | xxxx |
| Europe | xxxx | xxxx | xxxx | xxxx |
| United Kingdom | xxxx | xxxx | xxxx | xxxx |
| France | xxxx | xxxx | xxxx | xxxx |
| Germany | xxxx | xxxx | xxxx | xxxx |
| Italy | xxxx | xxxx | xxxx | xxxx |
| Russia | xxxx | xxxx | xxxx | xxxx |
| Spain | xxxx | xxxx | xxxx | xxxx |
| Sweden | xxxx | xxxx | xxxx | xxxx |
| Denmark | xxxx | xxxx | xxxx | xxxx |
| Switzerland | xxxx | xxxx | xxxx | xxxx |
| Luxembourg | xxxx | xxxx | xxxx | xxxx |
| Rest of Europe | xxxx | xxxx | xxxx | xxxx |
| Asia Pacific | xxxx | xxxx | xxxx | xxxx |
| China | xxxx | xxxx | xxxx | xxxx |
| Japan | xxxx | xxxx | xxxx | xxxx |
| South Korea | xxxx | xxxx | xxxx | xxxx |
| India | xxxx | xxxx | xxxx | xxxx |
| Australia | xxxx | xxxx | xxxx | xxxx |
| Singapore | xxxx | xxxx | xxxx | xxxx |
| Taiwan | xxxx | xxxx | xxxx | xxxx |
| South East Asia | xxxx | xxxx | xxxx | xxxx |
| Rest of APAC | xxxx | xxxx | xxxx | xxxx |
| South America | xxxx | xxxx | xxxx | xxxx |
| Brazil | xxxx | xxxx | xxxx | xxxx |
| Argentina | xxxx | xxxx | xxxx | xxxx |
| Colombia | xxxx | xxxx | xxxx | xxxx |
| Peru | xxxx | xxxx | xxxx | xxxx |
| Chile | xxxx | xxxx | xxxx | xxxx |
| Rest of South America | xxxx | xxxx | xxxx | xxxx |
| Middle East | xxxx | xxxx | xxxx | xxxx |
| Saudi Arabia | xxxx | xxxx | xxxx | xxxx |
| Turkey | xxxx | xxxx | xxxx | xxxx |
| UAE | xxxx | xxxx | xxxx | xxxx |
| Egypt | xxxx | xxxx | xxxx | xxxx |
| Qatar | xxxx | xxxx | xxxx | xxxx |
| Rest of Middle East | xxxx | xxxx | xxxx | xxxx |
| Africa | xxxx | xxxx | xxxx | xxxx |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | xxxx | xxxx | xxxx | xxxx |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Medicinal Cannabis Industrial News:
In April 2022, Dr. Reddy's Laboratories Ltd. and MediCane Health Inc. launched their medical cannabis product in Germany.
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| GreenWich | ••• | ••• | ••• | ••• |
| Abbvie | ••• | ••• | ••• | ••• |
| Insys Therapeutics | ••• | ••• | ••• | ••• |
| Bausch Health | ••• | ••• | ••• | ••• |
| Tilray | ••• | ••• | ••• | ••• |
| Corbus Pharmaceuticals | ••• | ••• | ••• | ••• |
| Aphria | ••• | ••• | ••• | ••• |
| Manitoba Harvest | ••• | ••• | ••• | ••• |
| Phytokann | ••• | ••• | ••• | ••• |
| Botanical Genetics | ••• | ••• | ••• | ••• |
| Jinzhou Qiaopai Biotech | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →Report Scope & Analysis
As per Cognitive Market Research's latest published report, the Global Medicinal Cannabis market size was USD 10,181.17 Million in 2022. Medicinal Cannabis Industry's Compound Annual Growth Rate will be 24.5% from 2023 to 2030.
What is Medicinal Cannabis?
Cannabinoids and marijuana prescribed by doctors to their patients are referred to as medicinal cannabis or medical marijuana. Due to production and political restrictions, marijuana has not been properly evaluated as a medicine. The safety and effectiveness of utilizing cannabis to treat illnesses, as a result, have not been thoroughly investigated through a clinical study.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Medicinal Cannabis Market Analysis is witnessing significant growth in the near future.
In 2023, the Buds/Marijuana Flower segment accounted for a notable share of the Medicinal Cannabis Market Analysis.
Frequently Asked Questions
★ Reviews
Rate this report
Medicinal Cannabis Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product Type | Buds/Marijuana Flower, Cannabis Extracts, Oil, Tinctures, Others |
| Application | Chronic Pain, Mental Disorders, Cancer, Others |
| Active Ingredients | Tetrahydrocannabinol (THC), Cannabidiol (CBD) |
| List of Competitors | GreenWich, Abbvie, Insys Therapeutics, Bausch Health, Tilray, Corbus Pharmaceuticals, Aphria, Manitoba Harvest, Phytokann, Botanical Genetics, Jinzhou Qiaopai Biotech |
-
1.1 Top Competitors Analysis
-
1.1.1 Global Medicinal Cannabis Market Analysis by Key Players
(Subject to Data Availability (Private Players))
- 1.1.2 Global Medicinal Cannabis Market Volume and Share by Key Players
- 1.1.3 Top Players Ranking 2024
- 1.1.4 New Product Launch Analysis
- 1.1.5 Industry Mergers and Acquisition Analysis
-
-
1.2 Company Profile (Data Subject to Availability) Sample Format
-
1.2.1 GreenWich
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 Financials (Subject to data availability)
- 1.2.1.4 R&D Investment (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
-
1.2.2 Abbvie
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 Financials (Subject to data availability)
- 1.2.2.4 R&D Investment (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
-
1.2.3 Insys Therapeutics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 Financials (Subject to data availability)
- 1.2.3.4 R&D Investment (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
-
1.2.4 Bausch Health
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 Financials (Subject to data availability)
- 1.2.4.4 R&D Investment (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
-
1.2.5 Tilray
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 Financials (Subject to data availability)
- 1.2.5.4 R&D Investment (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
-
1.2.6 Corbus Pharmaceuticals
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 Financials (Subject to data availability)
- 1.2.6.4 R&D Investment (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
-
1.2.7 Aphria
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 Financials (Subject to data availability)
- 1.2.7.4 R&D Investment (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
-
1.2.8 Manitoba Harvest
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 Financials (Subject to data availability)
- 1.2.8.4 R&D Investment (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
-
1.2.9 Phytokann
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 Financials (Subject to data availability)
- 1.2.9.4 R&D Investment (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
-
1.2.10 Botanical Genetics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.10.2 Business Overview
- 1.2.10.3 Financials (Subject to data availability)
- 1.2.10.4 R&D Investment (Subject to data availability)
- 1.2.10.5 Product Types Specification
- 1.2.10.6 Business Strategy
- 1.2.10.7 Recent Developments
- 1.2.10.8 Management Change
- 1.2.10.9 S.W.O.T Analysis
-
1.2.11 Jinzhou Qiaopai Biotech
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
- 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.11.2 Business Overview
- 1.2.11.3 Financials (Subject to data availability)
- 1.2.11.4 R&D Investment (Subject to data availability)
- 1.2.11.5 Product Types Specification
- 1.2.11.6 Business Strategy
- 1.2.11.7 Recent Developments
- 1.2.11.8 Management Change
- 1.2.11.9 S.W.O.T Analysis
-
- 2.1 Global Medicinal Cannabis Revenue Market Size, Trend Analysis 2022 - 2034
- 2.2 Global Medicinal Cannabis Volume Market Sales, Trend Analysis 2022 - 2034
-
2.3 Global Medicinal Cannabis Market Analysis By Regions 2022 - 2034
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- 2.3.1 Global Medicinal Cannabis Revenue Market Size By Region
- 2.3.2 Global Medicinal Cannabis Volume Market Sales By Region
-
2.4 Global Medicinal Cannabis Market Size By Product Type 2022 - 2034
- 2.4.1 Buds/Marijuana Flower Market Size
- 2.4.2 Cannabis Extracts Market Size
- 2.4.3 Oil Market Size
- 2.4.4 Tinctures Market Size
- 2.4.5 Others Market Size
-
2.5 Global Medicinal Cannabis Volume Market Sales By Product Type 2022 - 2034
- 2.5.1 Buds/Marijuana Flower Sales Volume
- 2.5.2 Cannabis Extracts Sales Volume
- 2.5.3 Oil Sales Volume
- 2.5.4 Tinctures Sales Volume
- 2.5.5 Others Sales Volume
-
2.6 Global Medicinal Cannabis Market Size By Application 2022 - 2034
- 2.6.1 Chronic Pain Market Size
- 2.6.2 Mental Disorders Market Size
- 2.6.3 Cancer Market Size
- 2.6.4 Others Market Size
-
2.7 Global Medicinal Cannabis Volume Market Sales By Application 2022 - 2034
- 2.7.1 Chronic Pain Sales Volume
- 2.7.2 Mental Disorders Sales Volume
- 2.7.3 Cancer Sales Volume
- 2.7.4 Others Sales Volume
-
2.8 Global Medicinal Cannabis Market Size By Active Ingredients 2022 - 2034
- 2.8.1 Tetrahydrocannabinol (THC) Market Size
- 2.8.2 Cannabidiol (CBD) Market Size
-
2.9 Global Medicinal Cannabis Volume Market Sales By Active Ingredients 2022 - 2034
- 2.9.1 Tetrahydrocannabinol (THC) Sales Volume
- 2.9.2 Cannabidiol (CBD) Sales Volume
- 2.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
2.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
- 2.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
- 2.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
- 2.11.3 Global Market Revenue Split By Product Type
- 2.11.4 Global Volume Market Split By Product Type
- 2.11.5 Global Market Revenue Split By Application
- 2.11.6 Global Volume Market Split By Application
- 2.11.7 Global Market Revenue Split By Active Ingredients
- 2.11.8 Global Volume Market Split By Active Ingredients
-
2.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
3.1 North America Medicinal Cannabis Market Outlook
- 3.1.1 North America Medicinal Cannabis Market Size 2022 - 2034
- 3.1.2 North America Medicinal Cannabis Volume Market Sales 2022 - 2034
- 3.1.3 North America Medicinal Cannabis Market Size By Country 2022 - 2034
- 3.1.4 North America Medicinal Cannabis Volume Market Sales By Country 2022 - 2034
-
3.1.5 North America Medicinal Cannabis Market Size by Product Type 2022 - 2034
- 3.1.5.1 North America Buds/Marijuana Flower Market Size
- 3.1.5.2 North America Cannabis Extracts Market Size
- 3.1.5.3 North America Oil Market Size
- 3.1.5.4 North America Tinctures Market Size
- 3.1.5.5 North America Others Market Size
-
3.1.6 North America Medicinal Cannabis Volume Market Sales by Product Type 2022 - 2034
- 3.1.6.1 North America Buds/Marijuana Flower Sales Volume
- 3.1.6.2 North America Cannabis Extracts Sales Volume
- 3.1.6.3 North America Oil Sales Volume
- 3.1.6.4 North America Tinctures Sales Volume
- 3.1.6.5 North America Others Sales Volume
-
3.1.7 North America Medicinal Cannabis Market Size by Application 2022 - 2034
- 3.1.7.1 North America Chronic Pain Market Size
- 3.1.7.2 North America Mental Disorders Market Size
- 3.1.7.3 North America Cancer Market Size
- 3.1.7.4 North America Others Market Size
-
3.1.8 North America Medicinal Cannabis Volume Market Sales by Application 2022 - 2034
- 3.1.8.1 North America Chronic Pain Sales Volume
- 3.1.8.2 North America Mental Disorders Sales Volume
- 3.1.8.3 North America Cancer Sales Volume
- 3.1.8.4 North America Others Sales Volume
-
3.1.9 North America Medicinal Cannabis Market Size by Active Ingredients 2022 - 2034
- 3.1.9.1 North America Tetrahydrocannabinol (THC) Market Size
- 3.1.9.2 North America Cannabidiol (CBD) Market Size
-
3.1.10 North America Medicinal Cannabis Volume Market Sales by Active Ingredients 2022 - 2034
- 3.1.10.1 North America Tetrahydrocannabinol (THC) Sales Volume
- 3.1.10.2 North America Cannabidiol (CBD) Sales Volume
-
4.1 Europe Medicinal Cannabis Market Outlook
- 4.1.1 Europe Medicinal Cannabis Market Size 2022 - 2034
- 4.1.2 Europe Medicinal Cannabis Volume Market Sales 2022 - 2034
- 4.1.3 Europe Medicinal Cannabis Market Size By Country 2022 - 2034
- 4.1.4 Europe Medicinal Cannabis Volume Market Sales By Country 2022 - 2034
-
4.1.5 Europe Medicinal Cannabis Market Size by Product Type 2022 - 2034
- 4.1.5.1 Europe Buds/Marijuana Flower Market Size
- 4.1.5.2 Europe Cannabis Extracts Market Size
- 4.1.5.3 Europe Oil Market Size
- 4.1.5.4 Europe Tinctures Market Size
- 4.1.5.5 Europe Others Market Size
-
4.1.6 Europe Medicinal Cannabis Volume Market Sales by Product Type 2022 - 2034
- 4.1.6.1 Europe Buds/Marijuana Flower Sales Volume
- 4.1.6.2 Europe Cannabis Extracts Sales Volume
- 4.1.6.3 Europe Oil Sales Volume
- 4.1.6.4 Europe Tinctures Sales Volume
- 4.1.6.5 Europe Others Sales Volume
-
4.1.7 Europe Medicinal Cannabis Market Size by Application 2022 - 2034
- 4.1.7.1 Europe Chronic Pain Market Size
- 4.1.7.2 Europe Mental Disorders Market Size
- 4.1.7.3 Europe Cancer Market Size
- 4.1.7.4 Europe Others Market Size
-
4.1.8 Europe Medicinal Cannabis Volume Market Sales by Application 2022 - 2034
- 4.1.8.1 Europe Chronic Pain Sales Volume
- 4.1.8.2 Europe Mental Disorders Sales Volume
- 4.1.8.3 Europe Cancer Sales Volume
- 4.1.8.4 Europe Others Sales Volume
-
4.1.9 Europe Medicinal Cannabis Market Size by Active Ingredients 2022 - 2034
- 4.1.9.1 Europe Tetrahydrocannabinol (THC) Market Size
- 4.1.9.2 Europe Cannabidiol (CBD) Market Size
-
4.1.10 Europe Medicinal Cannabis Volume Market Sales by Active Ingredients 2022 - 2034
- 4.1.10.1 Europe Tetrahydrocannabinol (THC) Sales Volume
- 4.1.10.2 Europe Cannabidiol (CBD) Sales Volume
-
5.1 Asia Pacific Medicinal Cannabis Market Outlook
- 5.1.1 Asia Pacific Medicinal Cannabis Market Size 2022 - 2034
- 5.1.2 Asia Pacific Medicinal Cannabis Volume Market Sales 2022 - 2034
- 5.1.3 Asia Pacific Medicinal Cannabis Market Size By Country 2022 - 2034
- 5.1.4 Asia Pacific Medicinal Cannabis Volume Market Sales By Country 2022 - 2034
-
5.1.5 Asia Pacific Medicinal Cannabis Market Size by Product Type 2022 - 2034
- 5.1.5.1 Asia Pacific Buds/Marijuana Flower Market Size
- 5.1.5.2 Asia Pacific Cannabis Extracts Market Size
- 5.1.5.3 Asia Pacific Oil Market Size
- 5.1.5.4 Asia Pacific Tinctures Market Size
- 5.1.5.5 Asia Pacific Others Market Size
-
5.1.6 Asia Pacific Medicinal Cannabis Volume Market Sales by Product Type 2022 - 2034
- 5.1.6.1 Asia Pacific Buds/Marijuana Flower Sales Volume
- 5.1.6.2 Asia Pacific Cannabis Extracts Sales Volume
- 5.1.6.3 Asia Pacific Oil Sales Volume
- 5.1.6.4 Asia Pacific Tinctures Sales Volume
- 5.1.6.5 Asia Pacific Others Sales Volume
-
5.1.7 Asia Pacific Medicinal Cannabis Market Size by Application 2022 - 2034
- 5.1.7.1 Asia Pacific Chronic Pain Market Size
- 5.1.7.2 Asia Pacific Mental Disorders Market Size
- 5.1.7.3 Asia Pacific Cancer Market Size
- 5.1.7.4 Asia Pacific Others Market Size
-
5.1.8 Asia Pacific Medicinal Cannabis Volume Market Sales by Application 2022 - 2034
- 5.1.8.1 Asia Pacific Chronic Pain Sales Volume
- 5.1.8.2 Asia Pacific Mental Disorders Sales Volume
- 5.1.8.3 Asia Pacific Cancer Sales Volume
- 5.1.8.4 Asia Pacific Others Sales Volume
-
5.1.9 Asia Pacific Medicinal Cannabis Market Size by Active Ingredients 2022 - 2034
- 5.1.9.1 Asia Pacific Tetrahydrocannabinol (THC) Market Size
- 5.1.9.2 Asia Pacific Cannabidiol (CBD) Market Size
-
5.1.10 Asia Pacific Medicinal Cannabis Volume Market Sales by Active Ingredients 2022 - 2034
- 5.1.10.1 Asia Pacific Tetrahydrocannabinol (THC) Sales Volume
- 5.1.10.2 Asia Pacific Cannabidiol (CBD) Sales Volume
-
6.1 South America Medicinal Cannabis Market Outlook
- 6.1.1 South America Medicinal Cannabis Market Size 2022 - 2034
- 6.1.2 South America Medicinal Cannabis Volume Market Sales 2022 - 2034
- 6.1.3 South America Medicinal Cannabis Market Size By Country 2022 - 2034
- 6.1.4 South America Medicinal Cannabis Volume Market Sales By Country 2022 - 2034
-
6.1.5 South America Medicinal Cannabis Market Size by Product Type 2022 - 2034
- 6.1.5.1 South America Buds/Marijuana Flower Market Size
- 6.1.5.2 South America Cannabis Extracts Market Size
- 6.1.5.3 South America Oil Market Size
- 6.1.5.4 South America Tinctures Market Size
- 6.1.5.5 South America Others Market Size
-
6.1.6 South America Medicinal Cannabis Volume Market Sales by Product Type 2022 - 2034
- 6.1.6.1 South America Buds/Marijuana Flower Sales Volume
- 6.1.6.2 South America Cannabis Extracts Sales Volume
- 6.1.6.3 South America Oil Sales Volume
- 6.1.6.4 South America Tinctures Sales Volume
- 6.1.6.5 South America Others Sales Volume
-
6.1.7 South America Medicinal Cannabis Market Size by Application 2022 - 2034
- 6.1.7.1 South America Chronic Pain Market Size
- 6.1.7.2 South America Mental Disorders Market Size
- 6.1.7.3 South America Cancer Market Size
- 6.1.7.4 South America Others Market Size
-
6.1.8 South America Medicinal Cannabis Volume Market Sales by Application 2022 - 2034
- 6.1.8.1 South America Chronic Pain Sales Volume
- 6.1.8.2 South America Mental Disorders Sales Volume
- 6.1.8.3 South America Cancer Sales Volume
- 6.1.8.4 South America Others Sales Volume
-
6.1.9 South America Medicinal Cannabis Market Size by Active Ingredients 2022 - 2034
- 6.1.9.1 South America Tetrahydrocannabinol (THC) Market Size
- 6.1.9.2 South America Cannabidiol (CBD) Market Size
-
6.1.10 South America Medicinal Cannabis Volume Market Sales by Active Ingredients 2022 - 2034
- 6.1.10.1 South America Tetrahydrocannabinol (THC) Sales Volume
- 6.1.10.2 South America Cannabidiol (CBD) Sales Volume
-
7.1 Middle East Medicinal Cannabis Market Outlook
- 7.1.1 Middle East Medicinal Cannabis Market Size 2022 - 2034
- 7.1.2 Middle East Medicinal Cannabis Volume Market Sales 2022 - 2034
- 7.1.3 Middle East Medicinal Cannabis Market Size By Country 2022 - 2034
- 7.1.4 Middle East Medicinal Cannabis Volume Market Sales By Country 2022 - 2034
-
7.1.5 Middle East Medicinal Cannabis Market Size by Product Type 2022 - 2034
- 7.1.5.1 Middle East Buds/Marijuana Flower Market Size
- 7.1.5.2 Middle East Cannabis Extracts Market Size
- 7.1.5.3 Middle East Oil Market Size
- 7.1.5.4 Middle East Tinctures Market Size
- 7.1.5.5 Middle East Others Market Size
-
7.1.6 Middle East Medicinal Cannabis Volume Market Sales by Product Type 2022 - 2034
- 7.1.6.1 Middle East Buds/Marijuana Flower Sales Volume
- 7.1.6.2 Middle East Cannabis Extracts Sales Volume
- 7.1.6.3 Middle East Oil Sales Volume
- 7.1.6.4 Middle East Tinctures Sales Volume
- 7.1.6.5 Middle East Others Sales Volume
-
7.1.7 Middle East Medicinal Cannabis Market Size by Application 2022 - 2034
- 7.1.7.1 Middle East Chronic Pain Market Size
- 7.1.7.2 Middle East Mental Disorders Market Size
- 7.1.7.3 Middle East Cancer Market Size
- 7.1.7.4 Middle East Others Market Size
-
7.1.8 Middle East Medicinal Cannabis Volume Market Sales by Application 2022 - 2034
- 7.1.8.1 Middle East Chronic Pain Sales Volume
- 7.1.8.2 Middle East Mental Disorders Sales Volume
- 7.1.8.3 Middle East Cancer Sales Volume
- 7.1.8.4 Middle East Others Sales Volume
-
7.1.9 Middle East Medicinal Cannabis Market Size by Active Ingredients 2022 - 2034
- 7.1.9.1 Middle East Tetrahydrocannabinol (THC) Market Size
- 7.1.9.2 Middle East Cannabidiol (CBD) Market Size
-
7.1.10 Middle East Medicinal Cannabis Volume Market Sales by Active Ingredients 2022 - 2034
- 7.1.10.1 Middle East Tetrahydrocannabinol (THC) Sales Volume
- 7.1.10.2 Middle East Cannabidiol (CBD) Sales Volume
-
8.1 Africa Medicinal Cannabis Market Outlook
- 8.1.1 Africa Medicinal Cannabis Market Size 2022 - 2034
- 8.1.2 Africa Medicinal Cannabis Volume Market Sales 2022 - 2034
- 8.1.3 Africa Medicinal Cannabis Market Size By Country 2022 - 2034
- 8.1.4 Africa Medicinal Cannabis Volume Market Sales By Country 2022 - 2034
-
8.1.5 Africa Medicinal Cannabis Market Size by Product Type 2022 - 2034
- 8.1.5.1 Africa Buds/Marijuana Flower Market Size
- 8.1.5.2 Africa Cannabis Extracts Market Size
- 8.1.5.3 Africa Oil Market Size
- 8.1.5.4 Africa Tinctures Market Size
- 8.1.5.5 Africa Others Market Size
-
8.1.6 Africa Medicinal Cannabis Volume Market Sales by Product Type 2022 - 2034
- 8.1.6.1 Africa Buds/Marijuana Flower Sales Volume
- 8.1.6.2 Africa Cannabis Extracts Sales Volume
- 8.1.6.3 Africa Oil Sales Volume
- 8.1.6.4 Africa Tinctures Sales Volume
- 8.1.6.5 Africa Others Sales Volume
-
8.1.7 Africa Medicinal Cannabis Market Size by Application 2022 - 2034
- 8.1.7.1 Africa Chronic Pain Market Size
- 8.1.7.2 Africa Mental Disorders Market Size
- 8.1.7.3 Africa Cancer Market Size
- 8.1.7.4 Africa Others Market Size
-
8.1.8 Africa Medicinal Cannabis Volume Market Sales by Application 2022 - 2034
- 8.1.8.1 Africa Chronic Pain Sales Volume
- 8.1.8.2 Africa Mental Disorders Sales Volume
- 8.1.8.3 Africa Cancer Sales Volume
- 8.1.8.4 Africa Others Sales Volume
-
8.1.9 Africa Medicinal Cannabis Market Size by Active Ingredients 2022 - 2034
- 8.1.9.1 Africa Tetrahydrocannabinol (THC) Market Size
- 8.1.9.2 Africa Cannabidiol (CBD) Market Size
-
8.1.10 Africa Medicinal Cannabis Volume Market Sales by Active Ingredients 2022 - 2034
- 8.1.10.1 Africa Tetrahydrocannabinol (THC) Sales Volume
- 8.1.10.2 Africa Cannabidiol (CBD) Sales Volume
- 9.1 Market Drivers
- 9.2 Market Restraints
- 9.3 Market Trends
- 9.4 Market Opportunity
- 9.5 Technological Road Map (Subject to Data Availability)
- 9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Customer and Buyer Behavior Analysis
- 9.7.1 Consumer Demographics and Target Audience Assessment
- 9.7.2 Consumer Purchase Behavior and Demand Assessment
- 9.7.3 Consumer Pricing Dynamics and Affordability Assessment
- 9.7.4 Digital Engagement, Customer Experience & Relationship Analysis
- 9.7.5 Future Consumption Trends and Demand Evolution Analysis
- 9.7.6 Enterprise Procurement & Purchasing Behavior Analysis
- 9.7.7 Customer Buying Behavior & Purchase Decision Analysis
- 9.7.8 Customer Expectations & Service Experience Evaluation
- 9.7.9 Vendor Selection, Supplier Preferences & Future Demand Trends
- 9.7.10 Customer Retention & Loyalty Strategy Assessment
- 9.7.11 Pricing, Affordability & Value Perception Analysis
- 9.7.12 Customer Segmentation & Demand Pattern Analysis
- 9.7.13 Relationship Management & Strategic Partnership Trends
- 9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
- 9.9.1 Political Factors
- 9.9.2 Economic Factors
- 9.9.3 Social Factors
- 9.9.4 Technological Factors
- 9.9.5 Legal Factors
- 9.9.6 Environmental Factors
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
- 9.10.1 Industry Chain Analysis
- 9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
- 9.10.3.1 Raw Material Analysis
- 9.10.3.2 Raw Material Procurement Analysis
- 9.10.3.3 Raw Material Price Trend Analysis
-
9.11 Porter’s Five Forces Analysis
- 9.11.1 Bargaining Power of Suppliers
- 9.11.2 Bargaining Power of Buyers
- 9.11.3 Threat of New Entrants
- 9.11.4 Threat of Substitutes
- 9.11.5 Degree of Competition
- 9.12 Patent Analysis (Subject to Data Availability)
- 9.13 ESG Analysis
-
9.14 Geopolitical Outlook
- 9.14.1 Global Power Realignment & Strategic Alliances
- 9.14.2 Geopolitical Risk Landscape & Conflict Hotspots
- 9.14.3 International Trade Relations & Market Access Environment
- 9.14.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 9.14.5 Supply Chain Resilience, Localization & Resource Nationalism
- 9.14.6 Technology Sovereignty & Digital Geopolitics
- 9.14.7 Strategic Implications for Investment, Growth & Market Entry
-
9.15 AI & Market Transformation
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
- 9.15.1 Competitive Landscape Disruption & Strategic Shifts
- 9.15.2 AI-Driven Transformation of Industry Value Chain
- 9.15.3 Evolution of Business Models & Revenue Streams
- 9.15.4 Operational Efficiency & Cost Structure Transformation
- 9.15.5 AI-Driven Product, Service & Innovation Transformation
- 9.15.6 Customer Behavior, AI Adoption & Future Market Evolution
- 9.15.7 Future Outlook: AI-Led Market Evolution & Strategic Implications
-
10.1 Buds/Marijuana Flower
- 10.1.1 Global Medicinal Cannabis Revenue Market Size and Share by Buds/Marijuana Flower 2022 - 2034
- 10.1.2 Global Medicinal Cannabis Volume Market Sales by Buds/Marijuana Flower 2022 - 2034
-
10.2 Cannabis Extracts
- 10.2.1 Global Medicinal Cannabis Revenue Market Size and Share by Cannabis Extracts 2022 - 2034
- 10.2.2 Global Medicinal Cannabis Volume Market Sales by Cannabis Extracts 2022 - 2034
-
10.3 Oil
- 10.3.1 Global Medicinal Cannabis Revenue Market Size and Share by Oil 2022 - 2034
- 10.3.2 Global Medicinal Cannabis Volume Market Sales by Oil 2022 - 2034
-
10.4 Tinctures
- 10.4.1 Global Medicinal Cannabis Revenue Market Size and Share by Tinctures 2022 - 2034
- 10.4.2 Global Medicinal Cannabis Volume Market Sales by Tinctures 2022 - 2034
-
10.5 Others
- 10.5.1 Global Medicinal Cannabis Revenue Market Size and Share by Others 2022 - 2034
- 10.5.2 Global Medicinal Cannabis Volume Market Sales by Others 2022 - 2034
-
11.1 Chronic Pain
- 11.1.1 Global Medicinal Cannabis Revenue Market Size and Share by Chronic Pain 2022 - 2034
- 11.1.2 Global Medicinal Cannabis Volume Market Sales by Chronic Pain 2022 - 2034
-
11.2 Mental Disorders
- 11.2.1 Global Medicinal Cannabis Revenue Market Size and Share by Mental Disorders 2022 - 2034
- 11.2.2 Global Medicinal Cannabis Volume Market Sales by Mental Disorders 2022 - 2034
-
11.3 Cancer
- 11.3.1 Global Medicinal Cannabis Revenue Market Size and Share by Cancer 2022 - 2034
- 11.3.2 Global Medicinal Cannabis Volume Market Sales by Cancer 2022 - 2034
-
11.4 Others
- 11.4.1 Global Medicinal Cannabis Revenue Market Size and Share by Others 2022 - 2034
- 11.4.2 Global Medicinal Cannabis Volume Market Sales by Others 2022 - 2034
-
12.1 Tetrahydrocannabinol (THC)
- 12.1.1 Global Medicinal Cannabis Revenue Market Size and Share by Tetrahydrocannabinol (THC) 2022 - 2034
- 12.1.2 Global Medicinal Cannabis Volume Market Sales by Tetrahydrocannabinol (THC) 2022 - 2034
-
12.2 Cannabidiol (CBD)
- 12.2.1 Global Medicinal Cannabis Revenue Market Size and Share by Cannabidiol (CBD) 2022 - 2034
- 12.2.2 Global Medicinal Cannabis Volume Market Sales by Cannabidiol (CBD) 2022 - 2034
- 13.1 Global Medicinal Cannabis Market Export Data (2022-2025)
- 13.2 Global Medicinal Cannabis Market Import Data by Region (2022-2025)
- 13.3 Global Medicinal Cannabis Market Export Data by Region (2022-2025)
- 13.4 North America Medicinal Cannabis Market Import Data by Country (2019-2023)
- 13.5 North America Medicinal Cannabis Market Export Data by Country (2019-2023)
- 13.6 Europe Medicinal Cannabis Market Import Data by Country (2019-2023)
- 13.7 Europe Medicinal Cannabis Market Export Data by Country (2019-2023)
- 13.8 Asia Pacific Medicinal Cannabis Market Import Data by Country (2019-2023)
- 13.9 Asia Pacific Medicinal Cannabis Market Export Data by Country (2019-2023)
- 13.10 South America Medicinal Cannabis Market Import Data by Country (2019-2023)
- 13.11 South America Medicinal Cannabis Market Export Data by Country (2019-2023)
- 13.12 Middle East and Africa Medicinal Cannabis Market Import Data by Country (2019-2023)
- 13.13 Middle East and Africa Medicinal Cannabis Market Export Data by Country (2019-2023)
- 15.1 Key Takeaways
-
15.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
- 15.3 Assumptions and Acronyms
-
16.1 Primary Data Collection
-
16.1.1 Steps for Primary Data Collection
- 16.1.1.1 Identification of KOL
- 16.1.2 Backward Integration
- 16.1.3 Forward Integration
- 16.1.4 How Primary Research Help Us
- 16.1.5 Modes of Primary Research
-
16.1.1 Steps for Primary Data Collection
-
16.2 Secondary Research
- 16.2.1 How Secondary Research Help Us
- 16.2.2 Sources of Secondary Research
-
16.3 Data Validation
- 16.3.1 Data Triangulation
- 16.3.2 Top Down & Bottom Up Approach
- 16.3.3 Cross check KOL Responses with Secondary Data
- 16.4 Data Representation
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Medicinal Cannabis Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Latest News about Medicinal Cannabis Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Medicinal Cannabis Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the medicinal cannabis market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report (250+ pages)
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.